• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo
- - - - -

does this anti-long COVID stack appear safe?

nac

  • Please log in to reply
1 reply to this topic

#1 ironfistx

  • Guest
  • 1,172 posts
  • 64
  • Location:Chicago

Posted 31 March 2022 - 10:05 PM


1g NAC x3 and 500mg sodium bicarbonate x3 (for 2-3 weeks)

300mg aspirin x1

 

Seems like a giant dose of NAC, that's 3g a day.

 

There were a bunch of supplements recommended but these were what I'm most wondering about.


Edited by ironfistx, 31 March 2022 - 10:06 PM.


#2 Danniel

  • Guest
  • 93 posts
  • 18
  • Location:München

Posted 18 April 2022 - 11:36 AM

There was a study about improving NAD+ and Glutathione levels to heal NAFLD and a side effect was the support in coping with COVID.

https://papers.ssrn....ract_id=3778301

 

 

The high mortality in COVID-19 patients is associated with hyperinflammatory response
er
and metabolic abnormalities, including the deficiency in NAD+ and glutathione metabolism.
Levels of NAD+ and glutathione could be critical for extinguishing the exacerbated inflammation
that triggers organ failure in COVID-19 patients and the risk for mortality. Given the lack of
targeted treatments for emerging viruses, the antiviral properties of repurposed drugs have gained
considerable attention (Altay et al., 2020a). In this context, we have hypothesized that
supplementation of CMCS would improve metabolic conditions associated with COVID-19,
increase the level of NAD+ and GSH, activate the mitochondrial metabolism in liver and other
tissues, and potentially accelerate the recovery of COVID-19 patients or reduce its severity. To
test this hypothesis, we have designed a randomized, controlled, open-label, placebo-controlled
study to evaluate the efficacy, tolerability, and safety of CMCS in ambulatory COVID-19 patients.
We recruited 93 patients randomly assigned to receive CMCS or placebo (3:1) for 14 days, and all
received hydroxychloroquine for five days as standard therapy (Altay et al., 2020b). We evaluated
the clinical status daily by phone and subject-reported presence or absence for COVID-19
symptoms and performed clinical chemistry, plasma inflammatory proteomics and metabolomics
analyses on Days 0 and 14. We observed that the time to complete recovery was significantly
shorter in the CMCS group (
6.6 vs 9.3 days).

 

Also:

 

CMCS treatment was given for 70 days after the initial diagnosis of high hepatic fat by MRI-PDFF. Patients in the treatment group took one dose of CMCS (3.73 g L-carnitine tartrate, 1 g nicotinamide riboside, 12.35 g serine, and 2.55 g N-acetyl-l-cysteine) daily for the first 14 days (after dinner) and two doses daily for the next 56 days (after breakfast and dinner).

 



sponsored ad

  • Advert
Click HERE to rent this advertising spot for SUPPLEMENTS (in thread) to support LongeCity (this will replace the google ad above).




Also tagged with one or more of these keywords: nac

1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users